MediBeacon Inc, based in Saint Louis, MO, is a leading medical technology company focused on developing fluorescent tracer agent-based systems for physiological monitoring. Their innovative technology enables the measurement and monitoring of vital organ systems, with a particular emphasis on nephrology, gastroenterology, ophthalmology, and surgery. With a strong commitment to quality and a team of industry leaders, MediBeacon aims to provide clinically practical solutions that can improve the standard of care while reducing healthcare costs.
Through their extensive preclinical and clinical studies, MediBeacon is advancing the use of fluorescence to measure and monitor disease progression. Their patent estate, which includes composition of matter, algorithm, and method patents, serves as a platform for continued innovation. With a focus on developing practical and accurate real-time point of care methodologies, MediBeacon's technology has the potential to revolutionize healthcare and impact global health.
Generated from the website